Pentixapharm Holding AG (ETR:PTP)
Germany · Delayed Price · Currency is EUR 1.892
+0.052 (2.83%)
At close: Mar 27, 2026
Pentixapharm Holding AG Revenue
In the year 2025, Pentixapharm Holding AG had annual revenue of 636.00K EUR, down -54.65%. Pentixapharm Holding AG had revenue of 519.00K in the quarter ending December 31, 2025, a decrease of -96.87%.
Revenue
636.00K
Revenue Growth
-96.16%
P/S Ratio
73.73
Revenue / Employee
9.94K
Employees
64
Market Cap
46.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 636.00K | -766.50K | -54.65% |
| Dec 31, 2024 | 1.40M | -5.11M | -78.47% |
| Dec 31, 2023 | 6.51M | 2.54M | 64.04% |
| Dec 31, 2022 | 3.97M | 1.37M | 52.67% |
| Dec 31, 2021 | 2.60M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.58B |
| Siemens Healthineers AG | 23.30B |
| Fresenius SE & Co. KGaA | 22.87B |
| Merck KGaA | 21.10B |
| Maternus-Kliniken Aktiengesellschaft | 116.17M |
| FamiCord AG | 88.29M |
| DocCheck AG | 56.12M |
| MeVis Medical Solutions AG | 16.06M |